Compass Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
KROS
Keros Therapeutics, Inc. |
$14.63 | $593.39 M | -85.94 | 163 |
KRON
Kronos Bio, Inc. |
$0.88 | $53.65 M | -0.82 | 8 |
MGTX
MeiraGTx Holdings plc |
$8.58 | $689.54 M | -3.71 | 375 |
CGEM
Cullinan Oncology, Inc. |
$7.78 | $457.95 M | -2.8 | 111 |
GOSS
Gossamer Bio, Inc. |
$1.50 | $338.68 M | -6.77 | 144 |
ANAB
AnaptysBio, Inc. |
$26.61 | $780.93 M | -5.58 | 136 |
MLTX
MoonLake Immunotherapeutics |
$50.22 | $3.19 B | -21.83 | 100 |
FIXX
Homology Medicines, Inc. |
$2.11 | $3.02 M | -0.03 | 7 |
GPCR
Structure Therapeutics Inc. |
$19.43 | $1.11 B | -7.49 | 163 |
AVTE
Aerovate Therapeutics, Inc. |
$9.21 | $77.68 M | -0.05 | 4 |
ELVN
Enliven Therapeutics, Inc. |
$22.48 | $1.33 B | -11.74 | 62 |
IDYA
IDEAYA Biosciences, Inc. |
$22.54 | $1.97 B | -6.18 | 131 |
TYRA
Tyra Biosciences, Inc. |
$10.40 | $553.05 M | -6.38 | 60 |
NAMS
NewAmsterdam Pharma Company N.V. |
$22.08 | $2.48 B | -12 | 68 |
NVCT
Nuvectis Pharma, Inc. |
$8.42 | $176.11 M | -7.46 | 13 |
REPL
Replimune Group, Inc. |
$11.28 | $864.91 M | -3.65 | 479 |
PEPG
PepGen Inc. |
$1.29 | $42.21 M | -0.41 | 79 |
LYRA
Lyra Therapeutics, Inc. |
$8.70 | $13.92 M | -0.14 | 30 |
VIGL
Vigil Neuroscience, Inc. |
$8.06 | $384.12 M | -3.91 | 69 |
GLUE
Monte Rosa Therapeutics, Inc. |
$5.27 | $323.54 M | 43.83 | 142 |
IVA
Inventiva S.A. |
$3.31 | $177.20 M | -0.94 | 114 |
PRTC
PureTech Health plc |
$17.80 | $432.22 M | 8.57 | 80 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
